{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T11:08:47Z","timestamp":1772449727440,"version":"3.50.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T00:00:00Z","timestamp":1769990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T00:00:00Z","timestamp":1772409600000},"content-version":"vor","delay-in-days":28,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gen Thorac Cardiovasc Surg Cases"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Thymic adenocarcinoma is a rare histological subtype of thymic carcinoma. Non-mucinous enteric-type thymic adenocarcinomas are extremely rare.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case presentation<\/jats:title>\n                    <jats:p>A 54-year-old woman with an abnormality detected on chest radiography was admitted to our hospital. Chest computed tomography showed a 5.5-cm-diameter mass in the anterior mediastinum. Blood carcinoembryonic antigen (CEA) level was highly elevated at 127\u00a0ng\/ml (normal\u2009&lt;\u20095), while other tumor markers, including alpha-fetoprotein, \u03b2-human chorionic gonadotropin, and interleukin-2R levels, were normal. Radiological findings suggested that the tumor was a thymic epithelium (Masaoka stage III). Surgery is performed for diagnostic and therapeutic purposes. Intraoperative findings revealed extensive pericardial invasion requiring a median sternotomy. The left brachiocephalic vein, pericardium, and lungs were resected along with the tumor to achieve complete resection.<\/jats:p>\n                    <jats:p>\n                      Histological findings revealed that the tumor was composed of tall, columnar adenocarcinoma forming irregular lumina with no mucin production. Immunohistochemistry showed that cytokeratin 20 was partially positive and caudal type homeobox 2 was positive in approximately 50% of the tumor cells. Based on the morphological and immunohistochemical findings, enteric-type thymic adenocarcinoma was diagnosed per the 5th edition of the World Health Organization classification. The tumor was subtyped according to the Masaoka (stage IVB) and TNM classification criteria (T3N1M0 stage IVA). Plasma CEA levels decreased to normal levels after surgery. Further genetic analysis of the tumor revealed a pathogenic\n                      <jats:italic>TP53<\/jats:italic>\n                      stop-gain mutation (p.Arg213*), leading to the loss of p53 protein function. Postoperative adjuvant radiation therapy (54\u00a0Gy in 27 fractions) was administered under the suspicion of incomplete microscopic resection. Reportedly, the patient is in complete remission four years post-surgery.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      We encountered a rare case of non-mucinous enteric-type thymic adenocarcinoma harboring a pathogenic\n                      <jats:italic>TP53<\/jats:italic>\n                      mutation. Further studies are required to enunciate the features of this subtype of thymic carcinoma.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s44215-026-00240-x","type":"journal-article","created":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T10:16:22Z","timestamp":1770027382000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Non-mucinous, enteric-type thymic adenocarcinoma: genetic analysis of a case"],"prefix":"10.1186","volume":"5","author":[{"given":"Eiji","family":"Narusawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoichi","family":"Ohtaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Genichiro","family":"Ishii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seshiru","family":"Nakazawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natsuko","family":"Kawatani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohiro","family":"Yazawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuki","family":"Numajiri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuka","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keisuke","family":"Nimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken","family":"Shirabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,2]]},"reference":[{"key":"240_CR1","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.jtcvs.2014.09.124","volume":"149","author":"U Ahmad","year":"2015","unstructured":"Ahmad U, Yao X, Detterbeck F, Huang J, Antonicelli A, Filosso P, et al. Thymic carcinoma outcomes and prognosis: results of an international analysis. J Thorac Cardiovasc Surg. 2015;149:95\u2013100.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"240_CR2","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.humpath.2018.01.011","volume":"74","author":"N Kalhor","year":"2018","unstructured":"Kalhor N, Moran CA. Primary thymic adenocarcinomas: a clinicopathological and immunohistochemical study of 16 cases with emphasis on the morphological spectrum of differentiation. Hum Pathol. 2018;74:73\u201382.","journal-title":"Hum Pathol"},{"key":"240_CR3","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1007\/s11748-022-01779-6","volume":"70","author":"R Hamanaka","year":"2022","unstructured":"Hamanaka R, Nakano K, Tsuboi T, Hatanaka K, Kohno M, Masuda R, et al. Enteric-type thymic adenocarcinoma: a case report and literature review focusing on prognosis based on histological subtypes. Gen Thorac Cardiovasc Surg. 2022;70:501\u20135.","journal-title":"Gen Thorac Cardiovasc Surg"},{"key":"240_CR4","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.prp.2016.11.012","volume":"213","author":"AY Kwon","year":"2017","unstructured":"Kwon AY, Han J, Chu J, Choi Y, Jeong B, Ahn M, et al. Histologic characteristics of thymic adenocarcinomas: clinicopathologic study of a nine-case series and a review of the literature. Pathol Res Pract. 2017;213:106\u201312.","journal-title":"Pathol Res Pract"},{"key":"240_CR5","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1002\/dc.23806","volume":"46","author":"M Tamai","year":"2018","unstructured":"Tamai M, Ishida M, Ebisu Y, Okamoto Y, Miyasaka C, Ohe C, et al. Thymic enteric type adenocarcinoma: a case report with cytological features. Diagn Cytopathol. 2018;46:92\u20137.","journal-title":"Diagn Cytopathol"},{"key":"240_CR6","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1097\/PAS.0000000000000359","volume":"39","author":"B Moser","year":"2015","unstructured":"Moser B, Schiefer AI, Janik S, Marx A, Prosch H, Pohl W, et al. Adenocarcinoma of the thymus, enteric type: report of 2 cases, and proposal for a novel subtype of thymic carcinoma. Am J Surg Pathol. 2015;39:541\u20138.","journal-title":"Am J Surg Pathol"},{"key":"240_CR7","doi-asserted-by":"publisher","first-page":"331","DOI":"10.4132\/jptm.2015.04.16","volume":"49","author":"HY Jung","year":"2015","unstructured":"Jung HY, Cho H, Chung JH, Bae SB, Lee JH, Lee HJ, et al. A rare case of primary tubular adenocarcinoma of the thymus, enteric immunophenotype: a case study and review of the literature. J Pathol Transl Med. 2015;49:331\u20134.","journal-title":"J Pathol Transl Med"},{"key":"240_CR8","doi-asserted-by":"publisher","first-page":"102133","DOI":"10.1016\/j.ctrv.2020.102133","volume":"92","author":"F Conforti","year":"2021","unstructured":"Conforti F, Tarantino P, Trillo P, Pala L, Zagami P, Pirola S, et al. Pathological and clinical features of enteric adenocarcinoma of the thymus. A pooled analysis of cases from a reference center and systematic review of the literature. Cancer Treat Rev. 2021;92:102133.","journal-title":"Cancer Treat Rev"},{"key":"240_CR9","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1007\/s00595-012-0161-5","volume":"42","author":"K Teramoto","year":"2012","unstructured":"Teramoto K, Kawaguchi Y, Hori T, Hashimoto M, Kitamura S, Motoishi M, et al. Thymic papillo-tubular adenocarcinoma containing a cyst: report of a case. Surg Today. 2012;42:988\u201391.","journal-title":"Surg Today"},{"key":"240_CR10","first-page":"5890","volume":"8","author":"L Wang","year":"2015","unstructured":"Wang L, Wang D, Qian K, Lu D, Chen L, Zhao L, et al. Thymic adenocarcinoma associated with thymic cyst: a case report and review of literature. Int J Clin Exp Pathol. 2015;8:5890\u20135.","journal-title":"Int J Clin Exp Pathol"},{"key":"240_CR11","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1177\/1066896906290364","volume":"14","author":"T Sawai","year":"2006","unstructured":"Sawai T, Inoue Y, Doi S, Ikuta Y, Kimino K, Nakashima M, et al. Tubular adenocarcinoma of the thymus: case report and review of the literature. Int J Surg Pathol. 2006;14:243\u20136.","journal-title":"Int J Surg Pathol"},{"key":"240_CR12","unstructured":"WHO Classification of Tumors Editorial Board. WHO classification of tumors: thoracic tumors, 5th ed. Vol. 5. Lyon: International Agency for Research on Cancer; 2021. p. 377\u20138."},{"key":"240_CR13","doi-asserted-by":"publisher","first-page":"375","DOI":"10.2482\/haigan.52.375","volume":"52","author":"N Tanaka","year":"2012","unstructured":"Tanaka N, Matsumoto I, Oda M, Takizawa M, Waseda R, Watanabe G. A case of thymic non-papillary adenocarcinoma. Jpn J Lung Cancer. 2012;52:375\u201380.","journal-title":"Jpn J Lung Cancer"},{"key":"240_CR14","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1097\/JTO.0b013e3181803eee","volume":"3","author":"E Seki","year":"2008","unstructured":"Seki E, Aoyama K, Ueda M, Haga T, Nakazato Y, Iijima M, et al. Mucinous adenocarcinoma of the thymus: a case report. J Thorac Oncol. 2008;3:935\u20137.","journal-title":"J Thorac Oncol"},{"key":"240_CR15","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1038\/modpathol.3880175","volume":"13","author":"P Chu","year":"2000","unstructured":"Chu P, Wu E, Weiss LM. Cytokeratin 7 and cytokeratin 20 expression in epithelial neoplasms: a survey of 435 cases. Mod Pathol. 2000;13:962\u201372.","journal-title":"Mod Pathol"},{"key":"240_CR16","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1016\/S0959-8049(02)00008-4","volume":"38","author":"T Tot","year":"2002","unstructured":"Tot T. Cytokeratins 20 and 7 as biomarkers: usefulness in discriminating primary from metastatic adenocarcinoma. Eur J Cancer. 2002;38:758\u201363.","journal-title":"Eur J Cancer"},{"key":"240_CR17","doi-asserted-by":"publisher","first-page":"215","DOI":"10.2169\/internalmedicine.35.215","volume":"35","author":"S Yamashita","year":"1996","unstructured":"Yamashita S, Yamazaki H, Kato T, Yokota T, Matsumoto N, Matsukura S. Thymic carcinoma which developed in a thymic cyst. Intern Med. 1996;35:215\u20138.","journal-title":"Intern Med"},{"key":"240_CR18","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1111\/j.1440-1827.2011.02742.x","volume":"62","author":"JH Tsai","year":"2012","unstructured":"Tsai JH, Lee JM, Lin MC, Liau JY. Carcinoid tumor arising in a thymic bronchogenic cyst associated with thymic follicular hyperplasia. Pathol Int. 2012;62:49\u201354.","journal-title":"Pathol Int"},{"key":"240_CR19","doi-asserted-by":"publisher","first-page":"S3970","DOI":"10.21037\/jtd.2018.09.88","volume":"10","author":"Y Ozawa","year":"2018","unstructured":"Ozawa Y. The usefulness of radiographic imaging for predicting the resectability of thymic carcinoma. J Thorac Dis. 2018;10:S3970\u20132.","journal-title":"J Thorac Dis"},{"issue":"2","key":"240_CR20","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1007\/s11748-020-01439-7","volume":"69","author":"T Ito","year":"2021","unstructured":"Ito T, Suzuki H, Sakairi Y, Wada H, Nakajima T, Yoshino I. 18F-FDG-PET\/CT predicts grade of malignancy and invasive potential of thymic epithelial tumors. Gen Thorac Cardiovasc Surg. 2021;69(2):274\u201381.","journal-title":"Gen Thorac Cardiovasc Surg"},{"key":"240_CR21","doi-asserted-by":"publisher","first-page":"23","DOI":"10.21037\/med.2017.11.02","volume":"1","author":"AC Roden","year":"2017","unstructured":"Roden AC. Molecular changes are infrequent in thymic carcinomas but might represent targetable mutations. Mediastinum. 2017;1:23.","journal-title":"Mediastinum"},{"key":"240_CR22","doi-asserted-by":"publisher","first-page":"36","DOI":"10.21037\/med-23-48","volume":"8","author":"T Sakane","year":"2024","unstructured":"Sakane T, Haneda H, Okuda K. Insights into molecular aspects and targeted therapy of thymic carcinoma: a narrative review. Mediastinum. 2024;8:36.","journal-title":"Mediastinum"},{"key":"240_CR23","doi-asserted-by":"publisher","first-page":"E694","DOI":"10.21037\/jtd.2017.07.11","volume":"9","author":"I Sakanoue","year":"2017","unstructured":"Sakanoue I, Hamakawa H, Fujimoto D, Imai Y, Minami K, Tomii K, et al. KRAS mutation-positive mucinous adenocarcinoma originating in the thymus. J Thorac Dis. 2017;9:E694\u20137.","journal-title":"J Thorac Dis"},{"key":"240_CR24","doi-asserted-by":"publisher","first-page":"e659","DOI":"10.1016\/j.cllc.2020.10.010","volume":"22","author":"N Himuro","year":"2021","unstructured":"Himuro N, Kitami A, Tanaka Y, Ohashi S, Suzuki K, Ohara J, et al. STK11\/LKB1 mutation-positive primary thymic mucinous adenocarcinoma accompanied by cerebellar metastasis: a case report and literature review. Clin Lung Cancer. 2021;22:e659\u201364.","journal-title":"Clin Lung Cancer"},{"key":"240_CR25","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1186\/s12885-017-3282-9","volume":"17","author":"Y Lee","year":"2017","unstructured":"Lee Y, Park S, Lee SH, Lee H. Characterization of genetic aberrations in a single case of metastatic thymic adenocarcinoma. BMC Cancer. 2017;17:330.","journal-title":"BMC Cancer"}],"container-title":["General Thoracic and Cardiovascular Surgery Cases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s44215-026-00240-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s44215-026-00240-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s44215-026-00240-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T10:42:27Z","timestamp":1772448147000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s44215-026-00240-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,2]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["240"],"URL":"https:\/\/doi.org\/10.1186\/s44215-026-00240-x","relation":{},"ISSN":["2731-6203"],"issn-type":[{"value":"2731-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,2]]},"assertion":[{"value":"27 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study, including the NGS analyses, was conducted in accordance with the Declaration of Helsinki. The protocol was approved by the Ethics Committee of Gunma University Hospital (HS2021-164). Written informed consent to participate was obtained from the patient.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent for publication of the case details and accompanying images was obtained from the patient.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"8"}}